, a bio/informatics shared resource is still "open for business" - Visit the CDS website


Xanthine oxidase contributes to host defense against Burkholderia cepacia in the p47(phox-/-) mouse model of chronic granulomatous disease.

Segal BH, Sakamoto N, Patel M, Maemura K, Klein AS, Holland SM, Bulkley GB
Infect Immun. 2000 68 (4): 2374-8

PMID: 10722648 · PMCID: PMC97432 · DOI:10.1128/iai.68.4.2374-2378.2000

Chronic granulomatous disease (CGD) is an inherited disorder of the NADPH oxidase in which phagocytes are defective in generating superoxide and downstream microbicidal reactive oxidants, leading to recurrent life-threatening bacterial and fungal infections. Xanthine oxidase (XO) is another enzyme known to produce superoxide in many tissues. Using the p47(phox-/-) mouse model of CGD, we evaluated the residual antibacterial activity of XO. Clearance of Burkholderia cepacia, a major pathogen in CGD, was reduced in p47(phox-/-) mice compared to that in wild-type mice and was further inhibited in p47(phox-/-) mice by pretreatment with the specific XO inhibitor allopurinol. Hepatic B. cepacia burden was similar in the two genotypes, but allopurinol significantly reduced net hepatic killing and killing efficiency only in p47(phox-/-) mice. Clearance and killing of intravenous Escherichia coli was intact in p47(phox-/-) mice and was unaffected by pretreatment with allopurinol. In CGD, XO may contribute to host defense against a subset of reactive oxidant-sensitive pathogens.

MeSH Terms (17)

Allopurinol Animals Burkholderia cepacia Escherichia coli Female Free Radical Scavengers Genotype Granulomatous Disease, Chronic Liver Male Mice Mice, Inbred C57BL Mice, Knockout NADPH Oxidases Phagocytes Phosphoproteins Xanthine Oxidase

Connections (1)

This publication is referenced by other Labnodes entities:

Links